Particle.news

Download on the App Store

FDA Unveils ELSA AI System as Review Times Drop to Six Minutes

Internal critics warn the rushed rollout has led to failures on basic tasks.

Image
Image
Image
Image

Overview

  • The agency deployed ELSA organization-wide ahead of schedule and under budget following a pilot that amassed thousands of staff interactions since January.
  • FDA Commissioner Marty Makary says tasks that once took two to three days now require just six minutes with ELSA’s assistance.
  • Built by Deloitte on Anthropic’s Claude LLM, ELSA operates within a secure GovCloud environment and does not train on industry-submitted data.
  • Staffers describe the tool as buggy and lacking policy guardrails, cautioning against its use for scientific reviews until functionality stabilizes.
  • ELSA currently aids in summarizing adverse event data, comparing drug labels, generating basic database code and prioritizing inspection sites, with plans for iterative improvements based on user feedback.